New research has warned that patients cured of visceral leishmaniasis can continue to infect others for years after successful treatment, which is hampering efforts to eliminate the disease. The most severe form of...
Researchers often spend billions of dollars and countless hours developing new drugs, only for the vast majority to fail long before they reach human trials. In recent years, some of those developers have started...
Another year, another flu vaccine because so far scientists haven’t managed to make a vaccine that protects against all strains of flu. A new approach could end that ritual and protect against deadly pandemic flu. If...
Efforts to develop an effective vaccine for genital herpes, a common sexually transmitted disease, have largely failed. In a new study published in Nature, Yale researchers explore why, and their findings could lead to...
Structural feature may lead to antivirals for the common cold, polio, and other pathogens Discovery of a new feature of a large class of pathogenic viruses may allow development of new antiviral medications for the...
A study of influenza virus transmission in Nicaraguan households reveals new insights into the type of immune responses that may be protective against influenza virus infection, report investigators. The findings could...
Engineered immune cells may provide a novel way to protect at-risk populations from life-threatening viruses, according to a new study published on 17 May in Science Immunology. So far, the effects have only been...
In a study published in the Nature Communications, researchers from King’s College London have shown how skin vaccination can generate protective CD8 T-cells that are recruited to the genital tissues and could be...
Scientists from the University of Adelaide’s Research Centre for Infectious Diseases have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections, the world’s...
The search for a global Strep A vaccine has narrowed after researchers sequenced the DNA of more than 2000 Group A Streptococcus samples from around the world. Researchers from the Wellcome Sanger Institute, the...